Selecta Biosciences (NASDAQ:SELB) reported its Q1 earnings results on Thursday, May 5, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
Selecta Biosciences beat estimated earnings by 172.73%, reporting an EPS of $0.08 versus an estimate of $-0.11.
Revenue was up $22.95 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.1 which was followed by a 5.71% drop in the share price the next day.
Here's a look at Selecta Biosciences's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.07 | -0.07 | -0.12 | -0.12 |
| EPS Actual | 0.03 | -0.16 | 0 | -0.22 |
| Revenue Estimate | 17.58M | 12.19M | 6.24M | 7.52M |
| Revenue Actual | 29.94M | 24.43M | 19.66M | 11.05M |
To track all earnings releases for Selecta Biosciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
